FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Teva Pharmaceuticals Amoxicillin for Oral Suspension Recall

Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and…

Teva Pharmaceuticals USA, Inc. · Sellersville, PA

Risk level
Class III
Reported by FDA
Jul 24, 2013
Recall ID
D-803-2013
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Amoxicillin for Oral Suspension starting Jun 18, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-803-2013 on Jul 24, 2013. Reason: Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050. Status: Terminated.

Why it was recalled

Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.

Product description

Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.

Lot numbers, UPCs & expiration codes

Lot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-803-2013
Classification
Class III
Status
Terminated
Recall initiated
Jun 18, 2013
FDA report date
Jul 24, 2013
Quantity
109,080 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-803-2013, exactly as published.

Show all FDA fields
City
Sellersville
State
PA
Status
Terminated
Country
United States
Event ID
65516
Address
650 Cathill Rd
Code information
Lot #s: a) 35426557A, 35426558A, Exp 08/14; b) 35426554A, 35426555A, 35426556A, Exp 08/14
Postal code
18960-1512
Report date
Jul 24, 2013
Product type
Drugs
Recall number
D-803-2013
Classification
Class III
Recalling firm
Teva Pharmaceuticals USA, Inc.
Product quantity
109,080 Bottles
Termination date
Dec 24, 2013
Reason for recall
Discoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDC 0093-4160-73, Rx Only, Manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B2K9, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960.
Distribution pattern
Nationwide
Recall initiation date
Jun 18, 2013
Initial firm notification
Letter
Center classification date
Jul 17, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-803-2013, published Jul 24, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls